24th January 2020 all-day
Prague, Czech Republic
The Executive Committee is the body responsible for governing the European Huntington’s Disease Network (EHDN), directing and overseeing its activities and establishing its strategy.
The Committee meets monthly and endorses clinical trials, approves access to clinical data and biosamples from the Registry study, and approves seed fund applications twice per year. Its members are elected by majority vote of the EHDN membership for a term of four years.
January 24 they meet in Prague, Czech Republic.
Find all the members of the Executive Committee here.